Treating With BTK Inhibitors in Practice
Symposium | First-line BTK inhibitors in clinical practice for CLL: Case study clinicПодробнее
BTK Inhibition as an MS Treatment Modality: Where Do We Stand and Where Are We Headed?Подробнее
Crafting the New Treatment Mix in CLLПодробнее
Treating Persistent/Chronic ITP Current Care, Future PotentialПодробнее
Chairperson Perspective: Practice-Changing Strategies in Community Care Settings for Patients wit...Подробнее
What Clinicians Want to Know About Toxicity Considerations Associated with BTK InhibitorsПодробнее
Using BTK Inhibitors in Community PracticeПодробнее
Role of PI3K inhibitors in clinical practice: Uses and pitfallsПодробнее
Advances in Chronic Spontaneous UrticariaПодробнее
Progress With BTK Inhibitors: A Journey Through the Mechanisms of Covalent and Noncovalent OptionsПодробнее